$USD
  • €EUR
  • $USD
  • £GBP
Search

Cart

Loadding...
Home>Peptides>MOTS-c 5mg/vial 10mg/vial
MOTS-c  5mg/vial 10mg/vial

MOTS-c 5mg/vial 10mg/vial

$USD 78.87
specification
5mg/vial 10vials 5mg/vial 20vials 5mg/vial 50vials 5mg/vial 100vials 10mg/vial 10vials 10mg/vial 20vials 10mg/vial 50vials 10mg/vial 100vials

couriers: Royal Mail, Fedex, UPS, DHL, DPD etc.

payment method: pay by Paypal, Debit&Credit Card online.


Contact us for other payment methods: Apple Pay, Google Pay, Bank Transfer, Western Union, Money Gram, USDT and Bitcoin.

WhatsApp: +8613207152765


Telegram: t.me/barry2765



Copy and share this link on social network or send it to your friends

Copy
Adding to cart succeed
MOTS-c 5mg/vial 10mg/vial
color:red,size:xxl
Subtotal: $USD 0
View My Cart
    • Product Name: MOTS-c 5mg/vial 10mg/vial
    • Item NO.: 4573947
    • Weight: 0 kg = 0.0000 lb = 0.0000 oz
    • Category: Peptides
    • Creation Time: 2025-06-29
    • including shipping fee.
    • China to UK, by special line+Royal Mail delivery, 7-10 days
    • China to European Union, by special line+DHL,/UPS delivery, 10 days.
    • China to USA, Canada etc, by special line+USPS/Fedex delivery, 10-15 days.


    MOTS‐c is a peptide of 16 amino acids expressed by a mitochondrial gene. Research provides evidence that mitochondria play a key role in signaling and in energy production.

    MOTS-c regulates metabolic functions throughout the body, including turning glucose into usable energy. Preliminary studies show evidence for improved control over blood sugar levels for those with type 2 diabetes and obesity.

    Research also shows that skeletal muscle is the major target tissue of MOTS‐c. The skeletal muscle enhances insulin sensitivity and increases glucose uptake in myocytes (muscle cells) by activating the AMPK pathway and at the same time without increasing insulin. It is fair to call MOTS‐c an exercise‐mimetic, meaning it imitates exercise on the body. Exercise also increases muscle glucose uptake without stimulating insulin.

    AMPK (AMP‐activated protein kinase), was identified in 1999 as the master switch for metabolism and the central regulator of both glucose and lipid (fat) metabolism. Since then it has been a target for therapeutic intervention against metabolic conditions such as type‐2 diabetes.